• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu

Vaccines

-

Concluding Review Memo/E-mail for Rota CMC

From: Feigelstock, Dino
Sent: Wednesday, April 02, 2008 12:12 PM
To: Henchal, Laraine; Levis, Robin
Cc: Feinstone, Stephen; Krause, Philip; Vujcic, Luba; Weir, Jerry P.
Subject: concluding review memo/e-mail for Rota CMC

Laraine;

Upon further discussion and review of the --------------- step and the in process controls to measure product quality after ---------------, it has been concluded that GSK's use of the - --------- is appropriate and there are no remaining issues regarding this step in manufacturing.

Dino

 

Contact FDA

(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

1401 Rockville Pike

Suite 200N/HFM-47

Rockville, MD 20852-1448
-
-